SFH 400
SFH 401
SFH 402
Wesentliche Merkmale Hergestellt im Schmelzepitaxieverfahren Kathode galvanisch mit dem Gehuseboden verbunden Hohe Zuverlssigkeit Gute spektrale Anpassung an Si-Fotoempfnger Hermetisch dichtes Metallgehuse SFH 400: Gehusegleich mit SFH 216 SFH 401: Gehusegleich mit BPX 43, BPY 62 SFH 402: Gehusegleich mit BPX 38, BPX 65 Anwendungen Lichtschranken fr Gleich- und Wechsellichtbetrieb IR-Gertefernsteuerungen Sensorik Lichtgitter Typ Type SFH 400 SFH 400-3 SFH 401 SFH 401-3 SFH 402 SFH 402-3
2001-02-22
Features Fabricated in a liquid phase epitaxy process Cathode is electrically connected to the case High reliability Matches all Si-Photodetectors Hermetically sealed package SFH 400: Same package as SFH 216 SFH 401: Same package as BPX 43, BPY 62 SFH 402: Same package as BPX 38, BPX 65
Applications Photointerrupters IR remote control of various equipment Sensor technology Light-grille barrier
Gehuse Package 18 A3 DIN 41876 (TO-18), Glaslinse, hermetisch dichtes Gehuse, Anschlsse im 2.54-mm-Raster (1/10) 18 A3 DIN 41876 (TO-18) glass lens, hermetically sealed package, solder tabs lead spacing 2.54 mm (1/10)
Top; Tstg
Top; Tstg
40 + 100
V mA A mW K/W K/W
55
nm
6 15 40 0.25
2001-02-22
LB LW
H H H tr, tf
mm mm mm s
Co
40
pF
VF VF IR
V V A
mW
TCI
0.55
%/K
TCV TC
1.5 + 0.3
mV/K nm/K
2001-02-22
Ie typ.
300
320
120
190
40
40
mW/sr
2001-02-22
10
0 1.0
OHR01883
50 0.8 60
0.6
70
0.4
80 90
0.2 0
100
1.0
0.8
0.6
0.4
20
40
60
80
100
120
10
0 1.0
OHR01884
50 0.8 60
0.6
70
0.4
80 90
0.2 0
100
1.0
0.8
0.6
0.4
20
40
60
80
100
120
10
0 1.0
OHR01885
50 0.8 60
0.6
70
0.4
80 90
0.2 0
100
1.0
0.8
0.6
0.4
20
40
60
80
100
120
2001-02-22
Radiant Intensity
e = f (IF ) e 100 mA
OHR01037
Single pulse, tp = 20 s
e
10 2
e (100 mA)
F mA 300
250 200 150
10 1
60
40
10 0
20
50
10
920 960 1000 nm 1060
-1
0 880
10 -2
10 -1
10 0
A F
10 1
20
40
60
80 C 100 TA , TC
Forward Current
IF = f (VF)
Permissible Pulse Handling Capability IF = f (), TC = 25 C, RthJC = 160 K/W, duty cycle D = parameter
OHR01040
10 1 A
10 4 mA 5 D=
OHR01937
tP tP T
F
T D= 0.005 0.01 0.02 0.05 0.1
F mA 300
250 200 150 R thJA = 450 K/W 100 50
10 0
typ.
max.
10 3 5
0.2 0.5
10 -1
DC
10 -2
1.5
2.5
3.5
4 V 4.5 VF
10 2 10 -5
10 -4
10 -3
10 -2
10 0
20
40
60
80
100 C 130 TA , TC
2001-02-22
Cathode (SFH 480) Anode (SFH 216, SFH 400) Chip position 2.7 (0.106)
2.54 (0.100) spacing
0.45 (0.018)
SFH 401
.04
3)
0.45 (0.018)
(0
1.1
0.9
(0
.03
5)
SFH 402
0.45 (0.018)
0.9
(0 .0
1.1
Chip position
35
(0
(2.7 (0.106))
.04
3)
14.5 (0.571) 12.5 (0.492) Cathode (SFH 402, BPX 65) Anode (SFH 482)
Mae werden wie folgt angegeben: mm (inch) / Dimensions are specified as follows: mm (inch).
2001-02-22
1.1 (0 .04 3)
1.1 3) .04 (0 035) . (0 0.9
0.9 (0
.03
5)
Published by OSRAM Opto Semiconductors GmbH & Co. OHG Wernerwerkstrasse 2, D-93049 Regensburg All Rights Reserved. Attention please! The information describes the type of component and shall not be considered as assured characteristics. Terms of delivery and rights to change design reserved. Due to technical requirements components may contain dangerous substances. For information on the types in question please contact our Sales Organization. Packing Please use the recycling operators known to you. We can also help you get in touch with your nearest sales office. By agreement we will take packing material back, if it is sorted. You must bear the costs of transport. For packing material that is returned to us unsorted or which we are not obliged to accept, we shall have to invoice you for any costs incurred. Components used in life-support devices or systems must be expressly authorized for such purpose! Critical components 1 , may only be used in life-support devices or systems 2 with the express written approval of OSRAM OS. 1 A critical component is a component usedin a life-support device or system whose failure can reasonably be expected to cause the failure of that life-support device or system, or to affect its safety or effectiveness of that device or system. 2 Life support devices or systems are intended (a) to be implanted in the human body, or (b) to support and/or maintain and sustain human life. If they fail, it is reasonable to assume that the health of the user may be endangered. 2001-02-22 8